Código QR (código de barras bidimensional)

Management of BNT162b2 mRNA COVID-19 vaccine in children aged 5–11 years with allergies, asthma, and immunodeficiency: consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP)

Abstract BNT162b2 vaccine, developed by BioNTech and Pfizer ha recently approved for use in children aged 5 to 11 years. Recent data show evidence of safety on the administration and serious adverse events have been rarely reported. However, allergic systemic reactions could occur. In some cases, a...

Fuld beskrivelse

Na minha lista:
Principais autores: Elio Novembre, Mariangela Tosca, Carlo Caffarelli, Mauro Calvani, Fabio Cardinale, Riccardo Castagnoli, Elena Chiappini, Claudio Cravidi, Michele Miraglia Del Giudice, Marzia Duse, Amelia Licari, Sara Manti, Alberto Martelli, Giampaolo Ricci, Giuseppe Pingitore, Gian Luigi Marseglia
Format: Artigo
Sprog:Inglês
Udgivet: BMC 2022-05-01
Serier:Italian Journal of Pediatrics
Fag:
COVID-19
SARS-CoV-2
Vaccine
Children
Adverse event
Allergy
Online adgang:https://doi.org/10.1186/s13052-022-01272-z
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker